Metropolis Healt

METROPOLISHEALTHCARE26 Apr 2024

Healthcare

₹

+33.40 (+1.89%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Metropolis Healt

Metropolis Healt

Healthcare

METROPOLISHEALTHCARE26 Apr 2024

₹

+33.40 (+1.89%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
04-Nov-2023	D	This is to inform you that, the Board of Directors in their meeting held today i.e 4th November, 2023, has approved the declaration of an Interim Dividend of Rs. 4 per share and has fixed Friday, 17th November, 2023 as the record date.	17-Nov-2023
10-Feb-2023	D	This is to inform you that the Board of Directors of the Company at their Meeting held today i.e. Friday, February 10, 2023 have inter-alia: ii. Approved and Declared payment of an Interim Dividend at the rate of Rs. 8/- (Rupees Eight Only) per Equity Share on the Face Value of Rs. 2/- (Rupees Two Only) per Equity Share for the Financial Year 2022-23. The Board has fixed Thursday, February 23, 2023, as the 'Record Date'. The Interim Dividend will be paid to the shareholders within 30 days of declaration.	23-Feb-2023
11-Feb-2022	D	This is to inform you that the Board of Directors of the Company at their meeting held today have inter-alia approved and declared payment of an Interim Dividend at the rate of Rs. 8/- (Rupees Eight only) per Equity Share on the Face Value of Rs. 2/- (Rupees Two only) per Equity Share for the Financial Year 2021-22.	21-Feb-2022
10-Feb-2021	D	Board approved the following: Approved and declared payment of Interim Dividend at the rate of Rs. 8/- (Rupees Eight only) per equity share on the Face Value Rs. 2 (Rupees Two only) each for the financial year 2020- 2021.The interim dividend will be paid to the members whose names appear in the Register of Members / Register of beneficiaries as on the Record Date' i.e. February 19, 2021.The Interim Dividend will be paid to the shareholders within 30 days of declaration.	17-Feb-2021
06-Feb-2020	D	The Board, at their meeting held on February 06, 2020, transacted the following items of business(corporate actions): 1. Declared an interim dividend of Rs.8/- per equity share; 2. Fixed February 15, 2020 as record date for interim dividend and February 24, 2019 as payment date;	13-Feb-2020
04-Nov-2023	BC	This is to inform you that, the Board of Directors in their meeting held today i.e 4th November, 2023, has approved the declaration of an Interim Dividend of Rs. 4 per share and has fixed Friday, 17t	31-Mar-2024
02-Apr-2024	BC	Dr Sushil Kanubhai Shah	28-Mar-2024
14-Mar-2024	BC	HDFC Mutual Fund & PACs	12-Mar-2024
07-Feb-2024	BC	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Thursd	08-Feb-2024
02-Feb-2024	BC	Please find attached herewith, Unaudited Financial Results (Standalone & Consolidated) For quarter and nine months ended December 31, 2023. Please find attached herewith, disclosure for cessation	03-Feb-2024

No Rights has been declared by METROPOLISHEALTHCARE

Book Closure

Record Date	Split Date	Purpose
31-Mar-2024	-	This is to inform you that, the Board of Directors in their meeting held today i.e 4th November, 2023, has approved the declaration of an Interim Dividend of Rs. 4 per share and has fixed Friday, 17t
28-Mar-2024	-	Dr Sushil Kanubhai Shah
12-Mar-2024	-	HDFC Mutual Fund & PACs
08-Feb-2024	-	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Thursd
03-Feb-2024	-	Please find attached herewith, Unaudited Financial Results (Standalone & Consolidated) For quarter and nine months ended December 31, 2023. Please find attached herewith, disclosure for cessation

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Metropolis Healthcare Ltd ₹1,805.05(+33.40/1.89%)	1,805.05	+33.40	9,247.06	48.22	74.58	9.32
Shalby Ltd ₹279.75(-3.85/-1.36%)	279.75	-3.85	3,021.57	97.35	30.30	2.97
Fortis Healthcare Ltd ₹443.55(-1.30/-0.29%)	443.55	-1.30	33,486.17	71.45	439.36	3.72
Poly Medicure Ltd ₹1,633.20(+49.15/3.10%)	1,633.20	+49.15	15,674.05	68.79	65.68	11.83
Mohini Health & Hygiene Ltd ₹58.60(+2.20/3.90%)	58.60	+2.20	106.86	16.73	15.63	1.19
GPT Healthcare Ltd ₹176.05(-1.35/-0.76%)	176.05	-1.35	1,444.58	0.00	29.67	6.79

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	269.41	285.46	256.29	264.41	264.55	280.06
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	269.41	285.46	256.29	264.41	264.55	280.06
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	5.19	2.01	2.78	9.14	6.79	2.93
Total Income	274.60	287.46	259.07	273.54	271.35	282.99
Total Expenditure	210.58	217.98	198.03	196.69	199.05	205.00
PBIDT	64.01	69.48	61.04	76.86	72.29	77.99
Interest	5.24	5.62	5.83	6.30	5.97	6.92
PBDT	58.77	63.86	55.22	70.55	66.33	71.07
Depreciation	24.14	21.37	19.99	22.23	21.95	20.40
Tax	8.54	13.03	9.47	8.34	10.95	14.16
Deferred Tax	-0.61	-1.82	-0.37	0.06	0.60	-1.30
Reported Profit After Tax	26.70	31.28	26.13	39.93	32.83	37.82
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	26.70	31.28	26.13	39.93	32.83	37.82

EPS (Unit Curr.)	5.21	6.11	5.10	7.80	6.41	7.39
EPS (Adj) (Unit Curr.)	5.21	6.11	5.10	7.80	6.41	7.39
Calculated EPS (Unit Curr.)	5.21	6.11	5.10	7.80	6.41	7.39
Calculated EPS (Adj) (Unit Curr.)	5.21	6.11	5.10	7.80	6.41	7.39
Calculated EPS (Ann.) (Unit Curr.)	20.85	24.43	20.41	31.19	25.64	29.54
Calculated EPS (Adj) (Ann.) (Unit Curr.)	20.85	24.43	20.41	31.19	25.64	29.54
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	400.00	0.00
Equity	10.24	10.24	10.24	10.24	10.24	10.24
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	2.00	2.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	23.76	24.34	23.82	29.07	27.33	27.85
PBDTM(%)	21.81	22.37	21.55	26.68	25.07	25.38
PATM(%)	9.91	10.96	10.20	15.10	12.41	13.50

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	291.12	308.50	277.09	282.55	285.46	300.35
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	291.12	308.50	277.09	282.55	285.46	300.35
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.31	1.22	3.05	1.23	6.62	4.34
Total Income	293.42	309.72	280.14	283.77	292.08	304.68
Total Expenditure	226.27	233.69	214.15	212.26	214.97	221.32
PBIDT	67.15	76.03	65.99	71.51	77.11	83.37
Interest	5.31	5.68	5.98	6.17	6.11	6.99
PBDT	61.85	70.35	60.01	65.34	71.00	76.38
Depreciation	24.99	22.24	20.82	23.43	23.03	21.58
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	10.08	14.33	11.30	9.26	12.74	15.52
Deferred Tax	-0.51	-1.88	-1.09	-0.85	-0.63	-1.20
Reported Profit After Tax	27.29	35.66	28.98	33.49	35.86	40.48
Minority Interest After NP	0.13	0.21	0.18	0.13	0.07	0.15
Net Profit after Minority Interest	27.16	35.45	28.80	33.36	35.80	40.33

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	27.16	35.45	28.80	33.36	35.80	40.33

EPS (Unit Curr.)	5.30	6.92	5.62	6.51	6.99	7.88
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	400.00	0.00
Equity	10.24	10.24	10.24	10.24	10.24	10.24

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	23.07	24.65	23.82	25.31	27.01	27.76
PBDTM(%)	21.25	22.80	21.66	23.13	24.87	25.43
PATM(%)	9.37	11.56	10.46	11.85	12.56	13.48

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.24	10.23	10.22	10.13	10.04	9.54
Reserves Total	925.77	828.97	654.59	502.26	405.37	354.49
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	936.01	839.20	664.81	512.39	415.41	364.03
Secured Loans	79.05	258.55	0.00	0.00	17.34	0.00
Unsecured Loans	188.89	118.58	111.01	53.54	0.00	0.00
Total Debt	267.94	377.13	111.01	53.54	17.34	0.00
Total Liabilities	1203.95	1216.33	775.82	565.93	432.75	364.03
APPLICATION OF FUNDS :
Gross Block	1229.25	1131.13	392.59	265.23	204.38	185.53
Less : Accumulated Depreciation	163.48	126.40	85.50	49.45	41.47	28.51
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1065.77	1004.73	307.09	215.78	162.91	157.02
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	19.51	5.78	0.00	2.99	5.77	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	49.71	50.41	11.88	129.78	135.09	98.01
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	41.27	47.01	38.12	17.46	19.65	14.96
Sundry Debtors	126.19	140.47	130.50	124.40	118.27	81.81
Cash and Bank	42.94	115.36	380.62	132.01	25.80	29.62
Loans and Advances	41.97	36.59	28.33	28.21	37.98	26.28
Total Current Assets	252.37	339.43	577.57	302.07	201.70	152.65
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	122.91	137.96	134.37	111.32	75.31	58.17
Provisions	17.30	12.21	19.71	5.40	9.18	7.68
Total Current Liabilities	140.21	150.17	154.08	116.72	84.48	65.86
Net Current Assets	112.16	189.26	423.49	185.35	117.22	86.80
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	23.68	18.89	0.00	0.00
Deferred Tax Liability	76.76	79.73	14.35	14.14	5.99	5.25
Net Deferred Tax	-76.76	-79.73	9.33	4.75	-5.99	-5.25
Total Assets	1170.39	1170.45	751.79	538.65	415.00	336.58
Contingent Liabilities	1.40	3.50	15.43	14.38	11.97	10.72

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.24	10.23	10.22	10.13	10.04	9.54
Reserves Total	977.99	875.96	696.38	513.37	408.50	405.22
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	988.23	886.19	706.60	523.50	418.54	414.76
Minority Interest	2.48	1.97	1.46	1.66	1.43	14.37
Secured Loans	79.05	258.55	0.00	0.00	17.55	0.20
Unsecured Loans	187.33	120.01	112.27	66.70	0.23	0.53
Total Debt	266.38	378.56	112.27	66.70	17.78	0.73
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	13.57	12.61	9.30	10.09	5.25	5.95
Total Liabilities	1270.66	1279.33	829.63	601.95	443.00	435.81
APPLICATION OF FUNDS :
Gross Block	1295.53	1192.34	438.35	366.11	271.30	246.45
Less: Accumulated Depreciation	174.86	133.41	95.24	69.74	58.49	39.01
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1120.67	1058.93	343.11	296.37	212.81	207.44
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	19.51	5.78	0.00	2.99	5.77	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	14.81	15.51	10.08	14.32	33.29	102.18
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	44.59	51.11	40.55	24.40	26.10	21.19
Sundry Debtors	121.89	135.49	122.98	128.25	136.85	100.68
Cash and Bank	93.19	166.94	419.70	210.47	80.24	60.14
Loans and Advances	30.00	25.84	16.91	21.37	30.51	17.88
Total Current Assets	289.67	379.37	600.13	384.49	273.70	199.89
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	133.76	150.09	150.44	138.22	92.56	77.60
Provisions	18.93	14.21	20.18	10.33	14.19	12.48
Total Current Liabilities	152.70	164.30	170.62	148.55	106.74	90.07
Net Current Assets	136.98	215.07	429.51	235.94	166.96	109.82
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	25.18	24.98	28.82	13.90	3.66	5.30
Deferred Tax Liability	96.53	101.86	15.90	1.73	2.90	4.45
Net Deferred Tax	-71.35	-76.88	12.92	12.17	0.76	0.85
Other Assets	50.05	60.93	34.01	40.16	23.41	15.53
Total Assets
Contingent Liabilities	2.13	4.20	16.69	17.31	13.11	14.07

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	27.49	347.68	83.30	8.80	20.69
Net Cash from Operating Activities	237.74	244.04	236.23	156.13	56.43
Net Cash Used In Investing Activities	46.72	-736.21	59.42	-51.13	-4.35
Net Cash Used In Financing Activities	-287.87	171.97	-31.27	-46.37	-63.97
Net Inc./Dec In Cash And Cash Equivalents	-3.40	-320.19	264.38	58.63	-11.89
Cash And Cash Equivalents At End Of The Year	24.09	27.49	347.68	67.43	8.80

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

49.67%

FII Shareholding

18.90%

DII Shareholding

24.86%

Public Shareholding

6.57%

**Promoter pledged shareholding 49.67%

About Metropolis Healthcare Ltd

Metropolis Healthcare Ltd is in the Healthcare sector, having a market capitalization of Rs. 9249.62 crores. It has reported a sales of Rs. 269.41 crores and a net profit of Rs. 26.7 crores for the quarter ended December 2018. The company management includes Sushil Kanubhai Shah, Sushil Kanubhai Shah,Ameera Sushil Shah,VIVEK GAMBHIR,Sanjay Bhatnagar,MILIND SHRIPAD SARWATE,Anita Ramachandran,Hemant Sachdev,Neha Shah (Metropolis Healthcare Ltd) among others.

Chairman

Sushil Kanubhai Shah

Registered office

250 D Udyog Bhavan,Worli,Mumbai,Maharashtra,400030

FAX :

Background

Incorporation Year2000

Face Value₹2

Market Lot1

How to buy Metropolis Healt shares on nse?

To buy Metropolis Healt shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Metropolis Healt share price today?

The Metropolis Healt shares price on nse is Rs.1805.05 today.

What is the market cap of Metropolis Healt shares on NSE ?

The company has a market capitalization of Rs.9247.06Cr

What is the PE & PB ratio of Metropolis Healt shares ?

PE is 74.58 and PB is 9.32

What is the 52 Week High and Low of Metropolis Healt shares?

Metropolis Healt stock price high: Rs.1933.5 Metropolis Healt stock price low: Rs.1209.25